Screening and detection of heterogenous vancomycin intermediate Staphylococcus aureus in Hospital Kuala Lumpur Malaysia, using the glycopeptide resistance detection Etest and population analysis profiling
- PMID: 24470927
 - PMCID: PMC3892648
 - DOI: 10.4081/idr.2012.e20
 
Screening and detection of heterogenous vancomycin intermediate Staphylococcus aureus in Hospital Kuala Lumpur Malaysia, using the glycopeptide resistance detection Etest and population analysis profiling
Abstract
In a 3-month study done in Hospital Kuala Lumpur (HKL), 7 out of 320 methicillin resistant Staphylococcus aureus isolates were confirmed as heterogeneous vancomycin intermediate S. aureus (hVISA) using the glycopeptide resistance detection e-test and population analysis, giving a prevalence rate of 2.19%. This is the first report of hVISA in Malaysia.
Keywords: Hospital Kuala Lumpur.; heterogenous vancomycin intermediate Staphylococcus aureus (hVISA).
Conflict of interest statement
Conflict of interest: all other authors report no conflicts of interest.
References
- 
    
- Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 1997;350:1670–3. - PubMed
 
 - 
    
- Howden BP, Davies JK, Johnson PDR, et al. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin intermediate and heterogenous vancomycin-intermediate strains: resistant mechanism, laboratory detection and clinical implications. Clin Microbiol Rev. 2010;23:99–139. - PMC - PubMed
 
 - 
    
- Hanaki H, Kuwahara-Arai K, Boyel-Vavra S, et al. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother. 1998;42:199–209. - PubMed
 
 - 
    
- National surveillance of antibiotic resistance 2008. Available from: www.imr.gov.my/report/nsar.htm.
 
 
LinkOut - more resources
Full Text Sources
